A marijuana metabolite is a byproduct your body creates when it breaks down THC, the main psychoactive compound in cannabis. The most important one is called THC-COOH, a non-psychoactive compound that lingers in your system long after the high wears off. It’s the specific substance that standard drug tests look for, which is why understanding metabolites matters far more than understanding THC itself when it comes to detection windows and test results.
How Your Body Breaks Down THC
When you smoke or ingest cannabis, THC travels to your liver, where enzymes convert it into a series of breakdown products. The first major step produces a metabolite called 11-OH-THC, which is still psychoactive and actually crosses into the brain more easily than THC itself. This partly explains why edibles can feel stronger: when you eat cannabis, a larger proportion of THC passes through the liver first and gets converted to this more potent intermediate form.
From there, additional enzymes oxidize 11-OH-THC into THC-COOH, which has no psychoactive effects at all. THC-COOH is the main circulating metabolite found in your bloodstream and the one your body eventually eliminates through urine and feces. The liver enzyme responsible for about 70% of THC’s initial breakdown is part of the cytochrome P450 family, which also processes many common medications. That overlap means certain drugs can slow down or speed up THC metabolism, potentially affecting how long metabolites remain detectable.
Researchers have identified several dozen distinct THC metabolites in total, though most exist in trace amounts and don’t play a significant role in either drug effects or testing.
Why Metabolites Stay in Your Body So Long
THC and its metabolites are fat-soluble, meaning they dissolve in and bind to fat tissue rather than staying in your bloodstream. After repeated cannabis use, THC accumulates in fat cells throughout your body. In human studies, THC has been found in fat biopsies up to 28 days after the last exposure. Under normal conditions, THC passively diffuses back out of fat into the blood at a slow, steady rate, which is why the elimination timeline for cannabis is so much longer than for water-soluble drugs like alcohol.
What makes this process unpredictable is that anything triggering fat breakdown can release stored THC back into circulation at higher-than-normal levels. Animal research has demonstrated that both fasting and stress hormones significantly increased blood levels of THC and THC-COOH in subjects that had been repeatedly exposed to the drug. The researchers described this as a potential “reintoxication” effect, where periods of food deprivation or physical stress could elevate metabolite concentrations even days or weeks after someone last used cannabis. No metabolism of THC occurs inside the fat cell itself; the compound simply sits there until the fat is broken down and releases it.
What Drug Tests Actually Measure
Standard workplace drug tests screen for THC-COOH, not THC itself. The federal guidelines set by SAMHSA (the agency overseeing workplace testing) use a two-step process. The initial immunoassay screening test has a cutoff of 50 ng/mL. If your sample hits that threshold, it goes to a confirmatory test with a lower cutoff of 15 ng/mL. You only get a positive result if both tests come back above their respective cutoffs.
These cutoffs exist specifically to reduce false positives from trace exposure. The 50 ng/mL initial screen is high enough that casual environmental contact with cannabis smoke is unlikely to trigger it under normal circumstances. However, a Johns Hopkins study found that secondhand exposure in an unventilated room did produce detectable cannabinoid levels in both blood and urine of non-smokers. In ventilated spaces, the same exposure did not produce positive urine screens. So ventilation matters considerably for passive exposure scenarios.
Detection Windows by Test Type
How long THC-COOH remains detectable depends on how often you use cannabis, your body fat percentage, your metabolism, and which type of test is used.
Urine tests are the most common. For someone who uses cannabis once or a few times, metabolites typically clear within a few days to a week. For daily users, detection windows can stretch to 30 days or longer because of the ongoing release of THC from fat stores. The more body fat you carry and the more frequently you’ve used cannabis, the longer the tail end of that elimination curve extends.
Blood tests detect THC and its metabolites over a shorter window, generally hours to a couple of days for occasional users. Blood testing is more useful for identifying recent impairment rather than past use.
Hair tests have the widest detection window. Standard practice analyzes the first 3.9 centimeters of hair closest to the scalp, representing roughly the last three months of growth. Research on documented cannabis users found that 85% of daily users tested positive through hair analysis, compared to 52% of non-daily users who smoked one to five times per week. Hair testing is notably less reliable for lighter users: only 24% of non-daily users passed both the initial screening and confirmatory steps.
False Positives and Cross-Reactivity
Cannabis immunoassays are considered one of the more specific panels in drug testing, but false positives do occur. Common over-the-counter pain relievers like ibuprofen and naproxen have been reported to trigger false positives on initial screens. Other culprits include certain HIV medications, some anti-nausea drugs, high-dose B vitamins (riboflavin), and surprisingly, certain baby wash products. Synthetic cannabinoids can also cross-react with the assay.
This is why the two-step testing process exists. The confirmatory test uses a different, more precise method that specifically identifies THC-COOH and filters out cross-reactive substances. If you’re taking any medication that might interfere, disclosing it to the testing facility before your sample is collected can help ensure accurate interpretation.
CBD Products and Metabolite Testing
CBD (cannabidiol) is broken down through its own metabolic pathway, producing different compounds than THC does. Its two most common metabolites are 7-OH-CBD and 7-COOH-CBD, and standard drug panels do not screen for them. In theory, pure CBD should not trigger a positive marijuana test.
The practical concern is that many CBD products contain trace amounts of THC, sometimes more than their labels suggest. Full-spectrum CBD products legally contain up to 0.3% THC, and with heavy daily use, even that small percentage can generate enough THC-COOH to cross testing thresholds. If drug testing is a concern, broad-spectrum or isolate CBD products carry less risk, though no CBD product can guarantee zero THC content with absolute certainty.